Chief Executive Officer / Chief Financial Officer
Mr. Tysiak’s main responsibilities include company strategy, business development, sales & marketing, and investor relations. He joined BIOBASE in October 2001 as Interim CFO and became CEO and CFO in January 2002. Michael holds an Industrial Engineering degree (Diplom-Wirtschaftsingenieur) from Technical University Berlin, Germany and a Master degree in Management Science of Stevens Institute of Technology, Hoboken, NJ, USA.
In his corporate career Michael worked in six different responsible management positions at Procter & Gamble for about 9 years. He was in charge of Financial Management in the consumer industry and also in the international pharmaceutical industry. In these positions he achieved significant results, among those a turnaround, cost savings and M&A projects. Afterwards he took the responsibility as Chief Financial Officer at Mister Minit Germany and Czech for two years. Where he reorganized and restructured the company and installed a proper budgeting and reporting. Before he joined BIOBASE, he gained two years experience in the biotech industry as Chief Financial Officer of id Pharma. He prepared an IPO, closed a financing round, redesigned internal processes, installed budgeting and US GAAP reporting.
Dr. Frank G. Schacherer
Chief Technical Officer (CTO)
Dr. Schacherer’s responsibilities include general and product management, research and development, information technology, and production. He is also responsible for business development and commercialization of products. His focus is to translate biomedical knowledge and Omics data to improved health care results. Frank joined BIOBASE in 2005 as director of BIOBASE Corporation, the US subsidiary of BIOBASE GmbH, where he led the integration of the PROTEOME family of databases with the TRANSFAC and TRANSPATH databases. He then headed and developed Biobase Databases India Pvt. Ltd., the Indian subsidiary of BIOBASE. From 2008 to 2010, he was responsible for business development as Executive Vice President. Before joining BIOBASE, Dr. Schacherer worked as a consultant for database integration at SHS information systems and developed microarray expression and pathway analysis solutions at Miltenyi Biotech. Schacherer has a background in database integration, software development, systems biology, next generation sequence analysis, and pathway analysis.
Dr. Schacherer obtained an M.S, in biochemistry from the Free University of Berlin, and a Ph.D. in Bioinformatics from the Technical University of Braunschweig and the German Research Centre for Biotechnology. His thesis, focusing on a database for signal transduction pathways and simulation of such pathways, led to the development of the pathway databases at BIOBASE GmbH in 2000. Dr. Schacherer is a PMI certified project manager, and has managed and coordinated several scientific projects supported by European and National grants. Dr. Schacherer is a member of the International Society for Computational Biology (ISCB), of Bioinformation Systems e.V., of the BioPathways Consortium and of the BioPAX Consortium.